News & Updates

In the treatment of scabies infection in children up to 2 years of age, age-based ivermectin dosing yields high response rates and is well-tolerated, according to the open-label phase 2 ITCHY 2 study.

Treatment with nivolumab plus relatlimab results in a lower incidence of severe immune-related adverse events (irAEs), delayed onset of irAEs, and reduced rate of treatment discontinuation among patients with advanced cutaneous melanoma when compared with ipilimumab plus nivolumab, reports a study.

Pharmacists working in hospitals do not see themselves competent enough to handle cancer patients, a study has shown.

In the phase II VESPER-2 trial, the investigational injectable glucagon-like peptide-1 receptor agonist (GLP-1 RA) berobenatide shows robust reductions in weight and HbA1c in adults with obesity/overweight and type 2 diabetes (T2D).

Treatment with secukinumab helps reduce symptoms and disease activity in Chinese children with enthesitis-related arthritis, as shown in a retrospective study.

A novel single-use electronic colonoscope performs similarly as the conventional reusable system in terms of patient comfort, procedural outcomes, and safety, despite the inferior image quality, as shown in an exploratory randomized trial.

A novel active driving system for paediatric ventricular assist devices exhibits safety and reliability in children with heart failure, with no major malfunctions, according to a study.